Cost-of-illness of psoriasis - results of a German cross-sectional study.

D JungenM AugustinA LangenbruchN ZanderK ReichK StrömerD ThaciS PurwinsM RadtkeM Gutknecht

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2017)

Psoriasis induces a considerable economic burden. Between 2003 and 2014, costs have markedly shifted from hospital, out-of-pocket and indirect costs towards systemic drug costs.

Keyphrases

healthcare
adverse drug
drug induced
acute care